drugset / Trial / NCT01239992
Effect of Niacin/Laropiprant on Postprandial Lipoprotein Metabolism in Patients With Dyslipoproteinemia
NaSingle-groupOpen-labelTreatment
Summary
The study is designed to evaluate the effect of Niacin/Laropiprant on postprandial lipoprotein metabolism, postprandial glucose metabolism, postprandial monocyte function, and postprandial biomarkers of endothelial dysfunction and inflammation.
Timeline
- Start
- 2011-06
- Primary completion
- 2013-01
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Niacin | Small molecule | 2000 mg | — |
| Subject | laropiprant | Small molecule | 40 mg | — |